Cerevasc announces positive eShunt study results in elderly NPH patients
Cerevasc has today reported initial results from its pilot US Food and Drug Administration (FDA)-approved investigational device exemption (IDE) clinical study of the eShunt system in the treatment...
neuronewsinternational.com